Practical Geriatrics ›› 2024, Vol. 38 ›› Issue (11): 1167-1173.doi: 10.3969/j.issn.1003-9198.2024.11.018
Previous Articles Next Articles
Received:2024-01-01
Online:2024-11-20
Published:2024-11-21
CLC Number:
| [1] ZHANG L, WANG F, WANG L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. [2] MIAO J, LIANG R, TIAN X, et al. Contributors to nutritional status in continuous ambulatory peritoneal dialysis as practised in Henan Province, China[J]. Asia Pac J Clin Nutr, 2018, 27(2):318-321. [3] QUINTELA B C S F, CARIOCA A A F, DE OLIVEIRA J G R, et al. Dietary patterns and chronic kidney disease outcomes: a systematic review[J]. Nephrology: Carlton, 2021, 26(7):603-612. [4] CAMEROTTO C, CUPISTI A, D’ALESSANDRO C, et al. Dietary fiber and gut microbiota in renal diets[J]. Nutrients, 2019, 11(9):2149. [5] 中国医师协会肾脏内科医师分会, 中国中西医结合学会肾脏疾病专业委员会营养治疗指南专家协作组. 中国慢性肾脏病营养治疗临床实践指南(2021版)[J]. 中华医学杂志, 2021, 101(8):539-559. [6] STEPHEN A M, CHAMP M M, CLORAN S J, et al. Dietary fibre in Europe: current state of knowledge on definitions, sources, recommendations, intakes and relationships to health[J]. Nutr Res Rev, 2017, 30(2):149-190. [7] SU G, QIN X, YANG C, et al. Fiber intake and health in people with chronic kidney disease[J]. Clin Kidney J, 2021, 15(2):213-225. [8] XU H, HUANG X, RISÉRUS U, et al. Dietary fiber, kidney function, inflammation, and mortality risk[J]. Clin J Am Soc Nephrol, 2014, 9(12):2104-2110. [9] WEHEDY E, SHATAT I F, AL KHODOR S. The human microbiome in chronic kidney disease: a double-edged sword[J]. Front Med: Lausanne, 2022, 8:790783. [10] BOZZETTO L, COSTABILE G, DELLA PEPA G, et al. dietary fibre as a unifying remedy for the whole spectrum of obesity-associated cardiovascular risk[J]. Nutrients, 2018, 10(7):943. [11] O’GRADY J, O’CONNOR E M, SHANAHAN F. Review article: dietary fibre in the era of microbiome science[J]. Aliment Pharmacol Ther, 2019, 49(5):506-515. [12] O’GRADY J, SHANAHAN F. Dietary fiber and gastrointestinal disease: an evolving story[J]. Curr Gastroenterol Rep, 2018, 20(12):59. [13] SLAVIN J. Fiber and prebiotics: mechanisms and health benefits[J]. Nutrients, 2013, 5(4):1417-1435. [14] MIRMIRAN P, YUZBASHIAN E, ASGHARI G, et al. Dietary fibre intake in relation to the risk of incident chronic kidney disease[J]. Br J Nutr, 2018, 119(5):479-485. [15] YANG J, LI Q, HENNING S M, et al. Effects of prebiotic fiber xylooligosaccharide in adenine-induced nephropathy in mice[J]. Mol Nutr Food Res, 2018, 62(15): e1800014. [16] ROCCHETTI M T, COSOLA C, RANIERI E, et al. Protein-bound uremic toxins and immunity[J]. Methods Mol Biol, 2021, 2325:215-227. [17] EBERT T, PAWELZIK S C, WITASP A, et al. Inflammation and premature ageing in chronic kidney disease[J]. Toxins: Basel, 2020, 12(4):227. [18] MURKAMILOV I T. The bi-directional effect of markers of inflammation and a decrease in glomerular filtration rate in chronic kidney disease[J]. Klin Lab Diagn, 2022, 67(1):37-42. [19] TAWFIK A M, TAWFIK H M. Nontraditional risk factors in chronic kidney disease: correlation between creatinine clearance, Framingham risk score, endothelial dysfunction, and inflammation[J]. Egypt J Intern Med, 2022, 34(1):29. [20] KRISHNAMURTHY V M, WEI G, BAIRD B C, et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease[J]. Kidney Int, 2012, 81(3):300-306. [21] QI L, VAN DAM R M, LIU S, et al. Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women[J]. Diabetes Care, 2006, 29(2):207-211. [22] JIAO J, XU J Y, ZHANG W, et al. Effect of dietary fiber on circulating C-reactive protein in overweight and obese adults: a meta-analysis of randomized controlled trials[J]. Int J Food Sci Nutr, 2015, 66(1):114-119. [23] ESGALHADO M, KEMP J A, AZEVEDO R, et al. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial[J]. Food Funct, 2018, 9(12):6508-6516. [24] ERTHAL LEINIG C, PECOITS-FILHO R, KUNII L, et al. Low-fiber intake is associated with high production of intraperitoneal inflammation biomarkers[J]. J Ren Nutr, 2019, 29(4):322-327. [25] DEMIRCI B G, TUTAL E, EMINSOY I O, et al. Dietary fiber intake: its relation with glycation end products and arterial stiffness in end-stage renal disease patients[J]. J Ren Nutr, 2019, 29(2):136-142. [26] CHEN Y Y, CHEN D Q, CHEN L, et al. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease[J]. J Transl Med, 2019, 17(1):5. [27] RYSZ J, FRANCZYK B, ŁAWIŃSKI J, et al. The impact of CKD on uremic toxins and gut microbiota[J]. Toxins: Basel, 2021, 13(4): 252. [28] SIMENHOFF M L, DUNN S R, ZOLLNER G P, et al. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus[J]. Miner Electrolyte Metab, 1996, 22(1-3):92-96. [29] VAZIRI N D, WONG J, PAHL M, et al. Chronic kidney disease alters intestinal microbial flora[J]. Kidney Int, 2013, 83(2):308-315. [30] VAZIRI N D, ZHAO Y Y, PAHL M V. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment[J]. Nephrol Dial Transplant, 2016, 31(5):737-746. [31] USUDA H, OKAMOTO T, WADA K. Leaky gut: effect of dietary fiber and fats on microbiome and intestinal barrier[J]. Int J Mol Sci, 2021, 22(14):7613. [32] EBRAHIM Z, PROOST S, TITO R Y, et al. The effect of β-glucan prebiotic on kidney function, uremic toxins and gut microbiome in stage 3 to 5 chronic kidney disease (CKD) predialysis participants: a randomized controlled trial[J]. Nutrients, 2022, 14(4):805. [33] LI Y J, CHEN X, KWAN T K, et al. Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A[J]. J Am Soc Nephrol, 2020, 31(6):1267-1281. [34] BARTOLOMAEUS H, BALOGH A, YAKOUB M, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage[J]. Circulation, 2019, 139(11):1407-1421. [35] BEUKEMA M, FAAS M M, DE VOS P. The effects of different dietary fiber pectin structures on the gastrointestinal immune barrier: impact via gut microbiota and direct effects on immune cells[J]. Exp Mol Med, 2020, 52(9):1364-1376. [36] JIANG T, GAO X, WU C, et al. Apple-derived pectin modulates gut microbiota, improves gut barrier function, and attenuates metabolic endotoxemia in rats with diet-induced obesity[J]. Nutrients, 2016, 8(3):126. [37] VAZIRI N D, LIU S M, LAU W L, et al. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease[J]. PLoS One, 2014, 9(12): e114881. [38] WANG S, LV D, JIANG S, et al. Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease[J]. Clin Sci: Lond, 2019, 133(17):1857-1870. [39] LI Y J, MA J, LOH Y W, et al. Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose[J]. Front Cell Dev Biol, 2023, 11:1182570. [40] HUANG W, MAN Y, GAO C, et al. Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-κB signaling[J]. Oxid Med Cell Longev, 2020, 2020:4074832. [41] LIU Y, LI Y J, LOH Y W, et al. Fiber derived microbial metabolites prevent acute kidney injury through G-protein coupled receptors and HDAC inhibition[J]. Front Cell Dev Biol, 2021, 9:648639. [42] CLASE C M, CARRERO J J, ELLISON D H, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney Int, 2020, 97(1):42-61. [43] EL AMOURI A, DELVA K, FOULON A, et al. Potassium and fiber: a controversial couple in the nutritional management of children with chronic kidney disease[J]. Pediatr Nephrol, 2022, 37(7):1657-1665. [44] CLEGG D J, HEADLEY S A, GERMAIN M J. Impact of dietary potassium restrictions in CKD on clinical outcomes: benefits of a plant-based diet[J]. Kidney Med, 2020, 2(4):476-487. [45] CUMMINGS J H, HILL M J, JENKINS D J, et al. Changes in fecal composition and colonic function due to cereal fiber[J]. Am J Clin Nutr, 1976, 29(12):1468-1473. [46] MATHIALAHAN T, MACLENNAN K A, SANDLE L N, et al. Enhanced large intestinal potassium permeability in end-stage renal disease[J]. J Pathol, 2005, 206(1):46-51. [47] BABICH J S, KALANTAR-ZADEH K, JOSHI S. Taking the kale out of hyperkalemia: plant foods and serum potassium in patients with kidney disease[J]. J Ren Nutr, 2022, 32(6):641-649. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
